About Us
The State of Ohio is working with various healthcare leaders, stakeholders, and medical professionals to identify promising treatment practices, including Medication Assisted Treatment (MAT), for opioid dependent pregnant mothers eligible for or enrolled in Medicaid during and after pregnancy.
The goal of the Maternal Opiate Medical Supports (MOMS 1.0) collaborative, was to improve maternal and fetal health outcomes, improve family stability, and reduce costs of Neonatal Abstinence Syndrome (NAS) to Ohio's Medicaid program by providing treatment to pregnant mothers with opiate issues during and after pregnancy through a Maternity Care Home (MCH) model of care. The MCH model is a team based healthcare delivery model that emphasizes care coordination and wrap-around services engaging expecting mothers in a combination of counseling, MAT, and case management.